Pathophysiology, Diagnosis, and Treatment of Patients with Concomitant Severe Aortic Stenosis and Coronary Artery Disease: A Closer Look to the Unresolved Perplexity.
Giuseppe Di GioiaJozef BartunekTullio TesorioVladan VukcevicSrdjan B AleksandricMilan R DobricDanilo FrancoEmanuele BarbatoMarko BanovicPublished in: Journal of clinical medicine (2021)
Degenerative aortic stenosis (AS) and coronary artery disease (CAD) are the most prevalent cardiovascular diseases in developed countries, and they coexist in up to 50% of patients. The pathophysiological rationale behind concomitant AS and CAD is discussed in detail in this review, together with prognostic implications. Detecting CAD in patients with AS may be challenging, as AS may mask the existence and symptoms of CAD. The safety and reliability of invasive and non-invasive physiological assessment for epicardial coronary disease are also a matter of debate. Finally, the selection and timing of optimal treatment of CAD in patients with severe AS are still unclear. Given the aging of the population, the increase in the prevalence of AS, and the ongoing paradigm shift in its treatment, controversies in the diagnosis and treatment of CAD in the setting of AS are deemed to grow in importance. In this paper, we present contemporary issues in the diagnosis and management of CAD in patients with severe AS who are transcatheter aortic valve implantation (TAVI) candidates and provide perspective on the treatment approach.
Keyphrases
- physical activity
- coronary artery disease
- aortic stenosis
- transcatheter aortic valve implantation
- ejection fraction
- aortic valve replacement
- percutaneous coronary intervention
- transcatheter aortic valve replacement
- aortic valve
- cardiovascular events
- coronary artery bypass grafting
- left ventricular
- early onset
- sleep quality
- metabolic syndrome
- clinical trial
- end stage renal disease
- type diabetes
- heart failure
- drug induced
- prognostic factors
- atrial fibrillation
- chronic kidney disease